SCHEMBL18138716

SCHEMBL18138716

CCN(c1ccccc1)c1cc(C)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ ALDH1A1 P00352 7/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ GAA P10253 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KMT2A Q03164 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ HCAR3 P49019 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ TLR9 Q9NR96 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18138718 0.83 ALDH1A1 (0.43) TSHRALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL18138720 0.81 MEN1 (0.55) TSHRCYP3A4ALDH1A1SMN1; SMN2GAA
SCHEMBL18227143 0.77 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2GAANPSR1KMT2A
SCHEMBL11748283 0.76 KIF18A (0.48) TSHRCYP3A4ALDH1A1SMN1; SMN2NPSR1
SCHEMBL22338052 0.73 TP53 (0.44) TSHRNPSR1KMT2AMEN1MAPT
SCHEMBL6831372 0.73 MEN1 (0.70) ALDH1A1GAANPSR1KMT2AMEN1
SCHEMBL18138717 0.73 HCAR3 (0.41) ALDH1A1SMN1; SMN2KMT2AMEN1HCAR3
SCHEMBL29740661 0.72 TSHR (0.56) TSHRCYP3A4ALDH1A1SMN1; SMN2GAA
SCHEMBL11449805 0.72 HCAR3 (0.55) ALDH1A1SMN1; SMN2KMT2AMEN1HCAR3
SCHEMBL26119562 0.71 AKR1B1 (0.55) TSHRCYP3A4ALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10303053-B2 Diazo-resin, photoresist composition and method of preparing same BOE TECHNOLOGY GROUP CO., LTD. (CN) 2019-05-28 — — US disclosed
US-20160334704-A1 DIAZO-RESIN, PHOTORESIST COMPOSITION AND METHOD OF PREPARING SAME BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-11-17 — — US disclosed
EP-3081581-A1 DIAZORESIN, PHOTORESIST COMPOSITION AND PREPARATION METHOD OF PHOTORESIST COMPOSITION BOE Technology Group Co., Ltd. (CN) 2016-10-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10303053-B2 Diazo-resin, photoresist composition and method of preparing same LCP1, CAD, CDH1 TSHR 2245/4885CYP3A4 4273/4885ALDH1A1 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback